2014 Q3/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +1 Biogen Idec
7.2
2 +2 Kyowa Hakko Kirin UK
7.2
3 -2 Cytogen
7.1
4 +3 Kyorin Holdings
7.0
5 +5 Otsuka Pharmaceuticals Europe
7.0
6 +5 EISAI UK
6.4
7 +5 Wockhardt
6.4
8 +5 Actelion UK
6.4
9 +0 Kaken Pharmaceutical
6.4
10 -2 Galenica AG
6.3
11 -8 Taisho Pharmaceutical
6.3
12 -6 Vectura
6.2
13 +3 Otsuka Pharmaceuticals
6.2
14 +6 Genmab
6.1
15 +18 Recordati
6.1
16 +2 Meda Pharmaceuticals
6.0
17 +5 Servier UK
5.7
18 -1 EISAI
5.6
19 +16 KRKA
5.6
20 +3 Actelion
5.5
21 +3 Genzyme UK
5.4
22 +14 Bavarian Nordic
5.4
23 +38 Medivation
5.3
24 +4 Novartis UK
5.3
25 +115 Diffusion Pharmaceuticals
5.3
26 +19 Santen
5.3
27 +3 Dainippon Sumitomo
5.2
28 +207 Mitsubishi Tanabe Pharma Europe Ltd
5.2
29 +25 Daiichi-Sankyo UK
5.2
30 -4 Nippon Chemiphar
5.1
31 -4 Covence
5.1
32 +2 Valeant Pharmaceuticals
5.1
33 +54 Servier
5.0
34 -15 Yakult UK
5.0
35 +2 Dusa Pharmaceuticals
5.0
36 +17 Pfizer UK
4.9
37 +6 Boehringer Ingelheim
4.9
38 +32 Agennix
4.8
39 +40 MediGene
4.8
40 +6 Therabel
4.8
41 +6 CSL Behring UK
4.8
42 -17 Debiopharm
4.8
43 +6 Sanofi UK
4.8
44 +6 Galderma
4.8
45 -6 Laboratoires Thea
4.7
46 -5 Forest
4.7
47 +1 Stallergenes UK
4.7
48 -19 Zandu
4.7
49 -9 Apotex
4.7
50 -12 Alkermes
4.7


Changes in rank are compared to 2014 Q2/Global Life Sciences. Since then, 1 site left the survey and 51 sites could not be included in the rankings (1 fewer since last time). Build your own. Report statistics.